Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders.
作者信息
Sanacora G, Heimer H, Hartman D, Mathew S J, Frye M, Nemeroff C, Robinson Beale R
机构信息
Yale Depression Research Program, Yale University School of Medicine, New Haven, CT, USA.
Cure Alliance for Mental Illness, Providence, RI, USA.
出版信息
Neuropsychopharmacology. 2017 May;42(6):1179-1181. doi: 10.1038/npp.2016.193. Epub 2016 Sep 19.
Abstract
摘要
相似文献
1
Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders.平衡氯胺酮治疗情绪障碍的前景与风险
Neuropsychopharmacology. 2017 May;42(6):1179-1181. doi: 10.1038/npp.2016.193. Epub 2016 Sep 19.
2
The promise of ketamine for treatment-resistant depression: current evidence and future directions.氯胺酮治疗难治性抑郁症的前景：当前证据与未来方向。
Ann N Y Acad Sci. 2015 May;1345(1):47-58. doi: 10.1111/nyas.12646. Epub 2015 Feb 3.
3
[Biomarkers for Mood Disorders and a Novel Antidepressant (R)-ketamine].[情绪障碍的生物标志物与一种新型抗抑郁药（R）-氯胺酮]
Brain Nerve. 2017 Oct;69(10):1143-1148. doi: 10.11477/mf.1416200882.
4
Gender differences in abusers of amphetamine-type stimulants and ketamine in southwestern China.中国西南地区苯丙胺类兴奋剂和氯胺酮滥用者的性别差异。
Addict Behav. 2013 Jan;38(1):1424-30. doi: 10.1016/j.addbeh.2012.06.024. Epub 2012 Aug 17.
5
The role of GSK-3 in treatment-resistant depression and links with the pharmacological effects of lithium and ketamine: A review of the literature.糖原合成酶激酶-3在难治性抑郁症中的作用及其与锂盐和氯胺酮药理作用的联系：文献综述
Encephale. 2016 Apr;42(2):156-64. doi: 10.1016/j.encep.2016.02.003. Epub 2016 Mar 16.
6
Midazolam attenuates ketamine-induced abnormal perception and thought process but not mood changes.咪达唑仑可减轻氯胺酮引起的异常感知和思维过程，但不能减轻情绪变化。
Can J Anaesth. 2000 Sep;47(9):866-74. doi: 10.1007/BF03019666.
7
Psychiatric morbidity in ketamine users attending counselling and youth outreach services.接受咨询和青少年外展服务的氯胺酮使用者的精神疾病发病率
Subst Abus. 2015;36(1):67-74. doi: 10.1080/08897077.2014.935560. Epub 2014 Jul 14.
8
Mechanism of action of dextromethorphan/quinidine:comparison with ketamine.右美沙芬/奎尼丁的作用机制：与氯胺酮的比较。
CNS Spectr. 2013 Oct;18(5):225-7. doi: 10.1017/S109285291300062X.
9
The role of NMDA receptors in the pathophysiology and treatment of mood disorders.NMDA 受体在心境障碍的病理生理学和治疗中的作用。
Neurosci Biobehav Rev. 2014 Nov;47:336-58. doi: 10.1016/j.neubiorev.2014.08.017. Epub 2014 Sep 16.
10
Effect of intraoperative application of ketamine on postoperative depressed mood in patients undergoing elective orthopedic surgery.氯胺酮术中应用对择期骨科手术患者术后抑郁情绪的影响。
J Anesth. 2016 Apr;30(2):232-7. doi: 10.1007/s00540-015-2096-7. Epub 2015 Nov 18.
引用本文的文献
1
Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial.用于治疗抵抗性抑郁症的缓释氯胺酮片：一项随机安慰剂对照的 2 期试验。
Nat Med. 2024 Jul;30(7):2004-2009. doi: 10.1038/s41591-024-03063-x. Epub 2024 Jun 24.
2
Widespread reductions in cortical thickness following ketamine abuse.广泛的皮质厚度减少后，滥用氯胺酮。
J Psychiatry Neurosci. 2024 May 30;49(3):E182-E191. doi: 10.1503/jpn.230111. Print 2024 May-Jun.
3
Mitochondrial Metabolism in Major Depressive Disorder: From Early Diagnosis to Emerging Treatment Options.重度抑郁症中的线粒体代谢：从早期诊断到新出现的治疗选择
J Clin Med. 2024 Mar 17;13(6):1727. doi: 10.3390/jcm13061727.
4
Exploring pharmacological options for adolescent depression: a preclinical evaluation with a sex perspective.探索青少年抑郁症的药理学治疗方案：基于性别视角的临床前评估
Transl Psychiatry. 2022 Jun 1;12(1):220. doi: 10.1038/s41398-022-01994-y.
5
Ketamine treatment for depression: qualitative study exploring patient views.氯胺酮治疗抑郁症：探索患者观点的定性研究
BJPsych Open. 2021 Jan 11;7(1):e32. doi: 10.1192/bjo.2020.165.
6
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L'humeur Et De L'anxiété (Canmat) Concernant L'utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif Majeur.加拿大心境与焦虑治疗网络（CANMAT）成人重性抑郁障碍使用消旋卡前列甲酯治疗工作组推荐：加拿大心境与焦虑治疗网络（CANMAT）成人重性抑郁障碍使用消旋卡前列甲酯治疗工作组推荐。
Can J Psychiatry. 2021 Feb;66(2):113-125. doi: 10.1177/0706743720970860. Epub 2020 Nov 11.
7
Ketamine: The final frontier or another depressing end?氯胺酮：是最终的前沿领域还是又一个令人沮丧的结局？
Behav Brain Res. 2020 Apr 6;383:112508. doi: 10.1016/j.bbr.2020.112508. Epub 2020 Feb 1.
8
Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors.从根源上消除自杀：氯胺酮治疗自杀行为的临床前基础和临床证据。
Int J Mol Sci. 2018 Sep 23;19(10):2888. doi: 10.3390/ijms19102888.
9
Characteristics of patients expressing an interest in ketamine treatment: results of an online survey.对氯胺酮治疗感兴趣的患者特征：一项在线调查结果
BJPsych Open. 2018 Sep 5;4(5):389-392. doi: 10.1192/bjo.2018.51. eCollection 2018 Sep.
10
Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects.抑郁症患者和健康对照者氯胺酮和安慰剂交叉试验的血浆代谢组学分析。
Psychopharmacology (Berl). 2018 Oct;235(10):3017-3030. doi: 10.1007/s00213-018-4992-7. Epub 2018 Aug 16.
本文引用的文献
1
NMDAR inhibition-independent antidepressant actions of ketamine metabolites.氯胺酮代谢物的非NMDAR抑制依赖性抗抑郁作用。
Nature. 2016 May 26;533(7604):481-6. doi: 10.1038/nature17998. Epub 2016 May 4.
2
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression.静脉注射氯胺酮治疗治疗抵抗性抑郁症的双盲、随机、安慰剂对照、剂量频率研究。
Am J Psychiatry. 2016 Aug 1;173(8):816-26. doi: 10.1176/appi.ajp.2016.16010037. Epub 2016 Apr 8.
3
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.突触可塑性与抑郁症：应激和速效抗抑郁药带来的新见解。
Nat Med. 2016 Mar;22(3):238-49. doi: 10.1038/nm.4050.
4
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.氯胺酮和其他 NMDA 拮抗剂：抑郁症的早期临床试验和可能的机制。
Am J Psychiatry. 2015 Oct;172(10):950-66. doi: 10.1176/appi.ajp.2015.15040465.
5
Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?氯胺酮：在情绪障碍新型疗法的研发中是充满希望的道路还是虚假的预言？
Neuropsychopharmacology. 2015 Jan;40(2):259-67. doi: 10.1038/npp.2014.261. Epub 2014 Sep 26.
6
Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.重复氯胺酮输注治疗难治性重度抑郁症的快速和长期抗抑郁作用。
Biol Psychiatry. 2013 Aug 15;74(4):250-6. doi: 10.1016/j.biopsych.2012.06.022. Epub 2012 Jul 27.
Zotero 插件